1. Effects of Lentinan on Proliferation, Migration and Chemotherapy Sensitivity of Pancreatic Cancer Cells through the IL-6/STAT3/Notch Signaling Pathway
- Author
-
Dong ZHANG, Tongxing DENG, Fenggang WANG, Xiaobo LIN, Jiexi CHENG, and Yongchao MA
- Subjects
lentinan ,il-6/stat3/notch signaling pathway ,pancreatic cancer ,proliferation ,migration ,chemotherapy sensitivity ,Food processing and manufacture ,TP368-456 - Abstract
Objective: Lentinan (LNT) had been shown to have direct cytotoxicity on cancer cells. However, the mechanism of this anti-tumor effect was still unclear. The purpose of this study was to investigate the effect of lentinan on the proliferation, migration and chemosensitivity of pancreatic cancer cells and its mechanism. Methods: Capan-1 cells from pancreatic cancer were randomly divided into control group, IL-6 group and IL-6+LNT group. Cell survival rate was detected by MTT, expression levels of p-STAT3, STAT3, Notch1 and Hes1 were analyzed by Western blot, and cell migration was observed by Transwell test. The cisplatin resistant cell model (Capan-1/DDP) was established, and the semi-inhibitory concentration of cisplatin (IC50) was detected in each group, and the relative expression levels of Ki67, MMP-9, MRP1 and P-gp were analyzed. Capan-1/DDP cell line was selected for tumor formation test in nude mice to verify the effects of LNT on tumor weight and IL-6/STAT3/Notch signaling pathway in nude mice. Results: Lentinan (7.5~240 µg/mL) could inhibit proliferation of pancreatic cancer cells. Compared with the IL-6 group, the expression levels of p-STAT3/STAT3, Notch1 and Hes1 in IL-6+LNT group were significantly down-regulated, the proliferation rate and the migration level was significantly dcreased (P
- Published
- 2023
- Full Text
- View/download PDF